ArticleFrontiers in reproductive health2026
Autoimmune diseases in patients with different PCOS phenotypes.
Article in Frontiers in reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common heterogeneous condition characterized by reproductive disturbances and significant metabolic and other comorbidities. Nevertheless, the interrelations between autoimmune disorders and PCOS are still not clarified. Therefore, the present study aims to investigate the specter of systemic and organ-specific autoimmune disorders in a large group of PCOS patients, and to explore the possible interrelations between different PCOS phenotypes and the susceptibility to autoimmune disturbances. Methods: A total of 1,249 women with PCOS (18-44 years) were investigated retrospectively. The presence of autoimmune thyroiditis and other concomitant autoimmune diseases was recorded. The associations between autoimmune disorders, PCOS phenotypes, hyperandrogenism and obesity were explored. Results: The prevalence of autoimmune thyroiditis (AIT) in PCOS women was 20.3% similar to other European countries. Subclinical or overt hypothyroidism was observed in 13.45% of patients, while hyperthyroidism developed in 1%. The prevalence of AIT was not related to the PCOS phenotype, but it was increased in obese PCOS patients (23.6% vs. 18.6%, Conclusions: Organ-specific and systemic autoimmune disorders affect 22.6% of the PCOS women. The investigation of autoimmune markers in diabetic women with PCOS might be essential for the precise diagnosis. Further studies on associations between PCOS, skin and systemic inflammatory disorders might be of clinical importance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.